Truist Lowers Target Price for Insmed Amid Rising Competition

Truist has made the decision to lower its target price for Insmed, a move that comes as competitive pressures in the industry continue to increase.

This adjustment indicates a response to the changing dynamics within the market that may impact Insmed's performance.

Investors and analysts will likely be monitoring how these competitive factors influence Insmed's future prospects.